Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sitagliptin 50mg / Metformin 1g tablets
0601023ADAAAAAA
|
Metformin hydrochloride/sitagliptin | Metformin hydrochloride/sitagliptin | Endocrine System | 29,549 |
|
Janumet 50mg/1000mg tablets
0601023ADBBAAAA
|
Janumet | Metformin hydrochloride/sitagliptin | Endocrine System | 6,160 |
|
Sitagliptin 50mg / Metformin 850mg tablets
0601023ADAAABAB
|
Metformin hydrochloride/sitagliptin | Metformin hydrochloride/sitagliptin | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.